Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Dignitana publishes Year End Financial Report 2016

Financial Year End Report - Summary: +-------------------------+-------+------+----------------+----------------+|Key Ratios | | | | |+-------------------------+-------+------+----------------+----------------+| | | | | |+-------------------------+-------+------+----------------+----------------+|Dignitana Group  |Q42016 |Q42015|Full year   2016|Full year   2015|+-------------------------+-------+------+----------------+----------------+|

STRAX: YEAR-END REPORT FOR THE FINANCIAL YEAR 2016

Strax, the mobile accessory brand specialist, delivers strong growth and improved profitabilityThe Group’s sales for the period January 1 – December 31, 2016, amounted to MSEK 868.2 (747.6) corresponding to a growth of 16.1 (18.3) percent. The gross margin amounted to 28.0 (24.5) percent. The Group’s result for the period January 1 – December 31, 2016, amounted to MSEK 30.3 (11.5) corresponding to SEK 0.26 (0.10) per share. Equity as at December 31 2016 amounted to 173.5 (98.4) corresponding to SEK 1.47 (0.84) per share. The Group’s sales for Q4, October 1 – December 31, 2016,

Vicore Pharma resolves on directed share issues and publish notice for an extraordinary shareholders’ meeting

NOT FOR DISTRIBUTION OR PUBLIC RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH MEASURES WOULD BE IN VIOLATION OF APPLICABLE REGULATIONS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER, OR A SOLICITATION OF ANY OFFER, TO BUY OR SUBSCRIBE FOR ANY SECURITIES IN VICORE PHARMA IN ANY JURISDICTION. This press release has also been published in Swedish on February 23rd at 8.30 CET. The Board of Directors of Vicore Pharma Holding AB has resolved on two directed share issues, one pursuant to authorization from the

Share subscriptions with Raute Corporation's stock options 2010

RAUTE CORPORATION STOCK EXCHANGE RELEASE 23 FEBRUARY 2017 at 9:45 a.m.SHARE SUBSCRIPTIONS WITH RAUTE CORPORATION'S STOCK OPTIONS 2010 A total of 13,249 Raute's series A new shares have been subscribed for with Raute Corporation's stock options 2010 B and stock options 2010 C between January 17 and February 2, 2017. The entire subscription price EUR 92,318.37 will be entered in the invested non-restricted equity reserve. As a result of the subscriptions, the number of Raute's series A shares will increase from 3,215,301 pcs to 3,228,550 pcs and the total amount of shares from 4,206,462

Sectra launches extended image sharing solution at ECR—easier sharing with patients and others

Linköping, Sweden, February 23, 2017 - International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) is launching an extended image sharing solution that enables healthcare providers to digitally share medical images with patients, insurance companies and others in a rapid and secure manner. This is an extension of Sectra’s existing solution for sharing and collaboration between various healthcare organizations and systems. It will allow healthcare providers to give patients increased control of their medical data and to let them take a more active

IVISYS AB provides market update

Press releaseIVISYS AB556998-498123 February 2017 IVISYS AB (’IVISYS’) wishes to update the market about the company’s current situation and general progress. IVISYS continues to grow its pipeline of prospective projects and the current number of prospective projects has reached 53. In comparison to the 40 offers/projects, which were communicated in the end of October 2016, this represents an increase of 22 projects, since 3 of the previously mentioned projects has been turned into orders and 6 offers are no longer relevant (has been postponed or lost). The previously communicated

Trigon Agri A/S: Trigon Agri brings forward the date for the publication of the Annual Report 2016

Trigon Agri A/S will publish its Annual Report 2016 on 29th March 2017, at 8:00 CET, instead of, as earlier announced, on 31st March 2017. Investor enquiries  Mr. Simon Boughton, CEO of Trigon Agri A/S Tel: +372 6191 500, E-mail:  mail@trigonagri.com  About Trigon Agri A/S  Trigon Agri A/S is an integrated soft commodities production, storage and trading company with operations in Ukraine, Russia and Estonia. Trigon Agri A/S shares are traded on the main market of Nasdaq Stockholm. For subscription to Company announcements please contact us: mail@trigonagri.com If you

AQ Group: Year-end report 2016

Full year 2016 in brief · Net sales increased by 12% to SEK 3 289 million (2 931) · Operating profit (EBIT) increased by 39 % to SEK 281 million (202) · Profit after financial items (EBT) increased by 32 % to SEK 279 million (212) · Profit margin before tax (EBT) 8.5% (7.2) · Cash flow from operating activities increased by 77 % to SEK 290 million (166) · Equity ratio 60 % (58) · Earnings per share after tax increased by 38 % to SEK 13.01 (9.44) · The Board of Directors proposes a dividend of SEK 2.75 (2.25) Fourth quarter, October – December 2016 in brief ·

Trigon Agri A/S announces the date for the Annual General Meeting 2017

Trigon Agri A/S hereby, in accordance with article 6.2. of its Articles of Association, announces that the Annual General Meeting 2017 will be held on 20th April 2017 at 10:00 CET at the office of Plesner Law Firm, Amerika Plads 37, DK-2100 Copenhagen Ø, Denmark. Any proposals from the shareholders to include specific issues on the agenda shall be received by Trigon Agri A/S no later than by 9th March 2017. The notice convening the Annual General Meeting 2017 shall be published at least 3 weeks prior to the meeting.  Investor enquiries  Mr. Simon Boughton, CEO of Trigon Agri A/S

Year-end report 2016: Strong end to the year

All amounts in the report relate to the Group and are stated in SEK thousands, unless otherwise indicated. Figures in brackets refer to the corresponding period the previous year.Fourth quarter  · Revenue amounted to SEK 35,204 (3,155) thousand, an increase of 1016%.  · Adjusted operating profit/loss before depreciation and amortisation (adjusted EBITDA), excluding non-recurring items attributable to the acquisition of HLM, amounted to SEK 19,754 (-929) thousand. Non-recurring costs attributable to the HLM acquisition amounted to SEK 2,403 thousand.   · Operating profit/loss was

Annual General Meeting in Skanska AB

Skanska AB (publ) gives notice to the Annual General Meeting on Tuesday, April 4, 2017 at 10.00 in Stockholm Waterfront Congress Centre, Nils Ericsons Plan 4, Stockholm, Sweden. Registration will begin at 9.00 a.m. Coffee and cake will be served before the meeting.Notification etc. Shareholders who wish to participate in the Annual General Meeting (the “Meeting”) must be recorded in the share register maintained by Euroclear Sweden AB on Wednesday, March 29, 2017, and notification must be received by the company not later than March 29, 2017, preferably before 12.00 noon. Notice to

Selvaag Bolig ASA: Purchase of treasury shares

Selvaag Bolig ASA purchased 5 161 treasury shares on 22 February 2017. The shares were purchased at an average price of NOK 40.00. The shares were purchased for the company's share programmes for employees. After the transaction, Selvaag Bolig owns 522 811 treasury shares. Further information fromSverre Molvik, CFO, Selvaag Bolig ASATelephone: +47 401 00 585, e-mail: smo@selvaagbolig.no Selvaag Bolig ASA is a residential property developer controlling the entire value chain from acquisition of land to sale of homes. The company has several thousand homes under development at

Change in Apetit Group’s Management Team

Kaija Viljanen, Director of Apetit Group’s Grain Trade and Oilseeds Business and Managing Director of Avena Nordic Grain Oy, has announced her decision to retire by the end of 2017.  Antti Snellman, M.Sc. (Tech.), has been appointed Director of the Grain Trade and Oilseeds Business and Managing Director of Avena Nordic Grain Oy, under which these businesses belong. He will join Apetit on 1 June 2017, and assume responsibility for business operations on 1 September 2017.  Snellman's previous employment was at Altia, where he headed the Starch and Feed business unit, a part of the

Sale of shares in Bravida Holding AB (publ)

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM AN OFFER OF SECURITIES IN THE UNITED STATES OR ANY OTHER JURISDICTION.   PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. Bravissima Holding AB (the “Seller”) has sold in total 30,000,000 ordinary shares in Bravida Holding AB (publ), a company listed on Nasdaq Stockholm, (“Bravida”) through

Kindred Group plc to make a GBP 175.6m recommended cash offer for 32Red plc

The boards of Kindred Group and 32Red have reached an agreement on the terms of a recommended cash offer (“Offer”) pursuant to which Kindred Group will acquire the entire issued and to be issued share capital of 32Red. The Offer values 32Red at GBP 175.6m. 32Red is listed on the AIM market of the London Stock Exchange. This transaction is consistent with Kindred’s multi-brand strategy and will further enhance Kindred’s position in the online casino market in the UK.Founded in 2002, 32Red is a Gibraltar-based online gaming company, operating online casino, online poker, online bingo and

Schizophrenia linked to mother’s low weight during pregnancy

[PRESS RELEASE 23 FEB. 2017] Children born to mothers who gained too little weight during pregnancy were at increased risk for schizophrenia and other non-affective psychoses later in life, according to new epidemiological research from Karolinska Institutet in Sweden. The findings, which are published in the journal JAMA Psychiatry, confirm the results of several important historical studies that showed a link between exposure to famine while in the womb and increased risk of schizophrenia later in life.Non-affective psychoses are a set of severe psychiatric disorders including

Year-end report 2016

JANUARY – DECEMBER 2016 - Net sales amounted to SEK 311.6 (283.2) million- EBITDA was SEK 29.1 (12.8) million- Basic earnings per share were SEK -0.04 (-0.27) JULY – DECEMBER 2016 - Net sales amounted to SEK 162.1 (146.6) million- EBITDA was SEK 21.9 (10.1) million- Basic earnings per share were SEK 0.05 (-0.12) SIGNIFICANT EVENTS Increase in net sales and gross profit during the year- Net sales increased by 10% to SEK 311.6 million- Gross profit increased by 20% to SEK 158.7 million Positive EBITDA of SEK 29.1 million for the year- Continued sales growth with

Industry 4.0 in real – FlexLink shows state of the art solutions at Interpack

The potential of Industry 4.0 lies in utilizing digitalization as a means to increase the effectiveness of manufacturing operations to new levels. At Interpack 2017, FlexLink exhibits new innovative solutions for leveraging production efficiency. Visitors will learn about the benefits of FlexLink’s world of smart factory automation.FlexLink demonstrates state-of-the-art mechanical and digital integration of two packaging lines with machinery from the Coesia Group. Together with Acma, Emmeci, Hapa and Norden Machinery, FlexLink has set up a smart production line for luxury packaging. "At

Internationella Engelska Skolan - Interim Report (1 July - 31 December 2016)

Progress of operations in quarter 2 (October-December)  · Total operating income was up by 15.6% on the corresponding quarter of the previous year, mainly due to increased student numbers, and central government subsidies for the Lärarlönelyftet (teacher salary boost) and Läxhjälp (homework support) programs, and amounted to MSEK 544.4 (471.0) · The number of students in the Swedish operation at the end of the autumn term was 21,407 (19,795) · There were around 133,000 registrations on waiting lists at the end of the quarter, an increase of some 11,000 registrations, (9%)

Invitation to Bonava’s Capital Markets Day in Berlin

Bonava has the pleasure of inviting investors, analysts and the media to its Capital Markets Day on May 16, 2017 in Berlin.During the Capital Markets Day we will deep dive into Bonava’s strategy, financial development and strategically important business in Germany. The day will be rounded off with a visit to different projects under development by Bonava in the local area. The presentations will be held by President and CEO Joachim Hallengren, CFO Ann-Sofi Danielsson and Business Unit Manager of Bonava Germany Olle Boback. Time: Registration and coffee at 9:00 a.m. and conclude at 3:

WULFF GROUP PLC’S ANNUAL ACCOUNTS JAN 1 – DEC 31, 2016: Net sales and comparable operating profit declined, dividend remains at the same level

This is a summary of Wulff Group Plc’s annual accounts January 1 – December 2016. The annual accounts in full are attached to this stock exchange release. The report is also available at the website www.wulff.fi.WULFF GROUP: KEY POINTS JANUARY – DECEMBER 2016 · In 2016, net sales totalled EUR 59.3 million (EUR 68.8 million). Net sales decreased by -13.8 percent (-7.3 %). · In 2016, EBITDA was EUR 1.0 million (EUR 2.0 million). In 2016, EBITDA included a sale of company cars of EUR 0.2 million affecting the comparability. In 2015, EBITDA included write downs of inventories and fixed

A full year well-aligned with Humana’s objectives

Fourth quarter: October-December 2016 · Operating revenue amounted to SEK 1,681 M (1,521 incl. capital gain of SEK 62 M), an increase of 11% or SEK 160 M. · Operating profit was SEK 73 M (78). Operating profit adjusted for one-offs was SEK 73 M (60), equivalent to an operating margin of 4.3% (3.9).    · Net profit after tax for the period was SEK 34 M (47). · Earnings per share for the period before and after dilution were SEK 0.65 (0.56). · Operating cash flow was SEK -247 M (197). The change is primarily attributable to changed payment terms in Personal Assistance and

Wilson Therapeutics AB (publ) Year-end Report 2016

Good year-end data gives a promising start to 2017October 1 – December 31, 2016 · Net sales amounted to SEK 0.0 M (0.0) · Loss for the period was SEK 34.1 M (loss: 21.3) · Loss per share, before and after dilution, totaled SEK 1.33 (loss: 16.84) · At December 31, cash and cash equivalents amounted to SEK 386.6 M (31.4) January 1 – December 31, 2016 · Net sales amounted to SEK 0.0 M (0.0) · Loss for the period was SEK 115.2 M (loss: 70.5) · Loss per share, before and after dilution, totaled SEK 6.84 (loss: 55.53) · The board of directors proposes that no

There are no items matching the current filter
There are no more items matching the current filter
Back to top